Skip to main content

Table 1 ATEC scores at beginning at beginning of phase 1 and end of phase 2, for those who completed phase 2.

From: Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part B - Behavioral results

   Initial St dev Final St dev % change
I. SPLC 7 rounds 13.4 7.7 10.6 7.0 -21%***
  1 round 12.0 8.4 10.5 8.9 -13%
II. Sociability 7 rounds 16.6 8.5 12.1 6.5 -27%***
  1 round 14.9 6.8 11.2 6.5 -25%*
III. Sensory/Cognitive Awareness 7 rounds 16.0 7.4 11.7 7.9 -27%***
  1 round 13.0 6.8 9.6 5.9 -26%*
IV. Health/Physical/Behavior 7 rounds 29.9 14.4 21.6 10.1 -28%**
  1 round 21.5 9.4 18.3 9.2 -15%
ATEC Total 7 rounds 80.8 24.0 60.14 27.9 -26%***
  1 round 66.2 20.7 53.4 23.5 -19%**
  1. * P < 0.05
  2. **P < 0.01
  3. *** P < 0.001
  4. For the 7-round group n = 25 (n = 14 for Section IV & Total), and for the 1-round group n = 15 (n = 10 for Section IV & Total). The statistical significance of the change is indicated, based on a paired t-test.